FDA Approved: JORNAY PM EXTENDED-RELEASE — Supplemental Application (Ironshore Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Jornay PM Extended-Release (methylphenidate hydrochloride) by Ironshore Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• JORNAY PM EXTENDED-RELEASE (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for JORNAY PM EXTENDED-RELEASE (METHYLPHENIDATE HYDROCHLORIDE)